Opioid dependence treatment, including buprenorphine/naloxone (Q34533873)

2 August 2017

1 reference

title

Opioid dependence treatment, including buprenorphine/naloxone (English)

1 reference

2 August 2017

0 references

Dennis W Raisch

1

1 reference

2 August 2017

Carol L Fye

series ordinal

2

1 reference

2 August 2017

Kathy D Boardman

series ordinal

3

1 reference

2 August 2017

Mike R Sather

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Annals of Pharmacotherapy

2 August 2017

1 reference

2 August 2017

36

1 reference

2 August 2017

2

1 reference

2 August 2017

312-321

1 reference

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial

2 August 2017

1 reference

HIV transmission and the cost-effectiveness of methadone maintenance.

21 January 2018

1 reference

Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment

21 January 2018

1 reference

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

21 January 2018

1 reference

Treating opioid dependence--new data and new opportunities

21 January 2018

1 reference

Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy

21 January 2018

1 reference

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

21 January 2018

1 reference

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

21 January 2018

1 reference

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

21 January 2018

1 reference

Rapid and ultrarapid opioid detoxification techniques

21 January 2018

1 reference

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence

21 January 2018

1 reference

21 January 2018

1 reference

Lethal methadone intoxications in Geneva, Switzerland, from 1994 to 1998.

21 January 2018

1 reference

21 January 2018

1 reference

Toxicology and pathology of deaths related to methadone: retrospective review

21 January 2018

1 reference

Methadone maintenance programs--a two-edged sword?

21 January 2018

1 reference

21 January 2018

1 reference

Subjective and physiologic effects of intravenous buprenorphine in humans.

21 January 2018

1 reference

The animal pharmacology of buprenorphine, an oripavine analgesic agent

21 January 2018

1 reference

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

21 January 2018

1 reference

Analgesic effectiveness of the narcotic agonist-antagonists

21 January 2018

1 reference

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

Effects of sublingually given naloxone in opioid-dependent human volunteers

21 January 2018

1 reference

Sublingual versus subcutaneous buprenorphine in opiate abusers.

21 January 2018

1 reference

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

21 January 2018

1 reference

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

21 January 2018

1 reference

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

21 January 2018

1 reference

The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand

21 January 2018

1 reference

A controlled trial of buprenorphine treatment for opioid dependence

21 January 2018

1 reference

A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.

21 January 2018

1 reference

Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

21 January 2018

1 reference

Characterization of prototypical opioid antagonists, agonist-antagonists, and agonists in the morphine-dependent rhesus monkey

21 January 2018

1 reference

A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence

21 January 2018

1 reference

A comparison of four buprenorphine dosing regimens using open-dosing procedures: is twice-weekly dosing possible?

21 January 2018

1 reference

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

21 January 2018

1 reference

Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans

21 January 2018

1 reference

Safety and side-effects of buprenorphine in the clinical management of heroin addiction

21 January 2018

1 reference

Six deaths linked to concomitant use of buprenorphine and benzodiazepines

21 January 2018

1 reference

Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities

21 January 2018

1 reference

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.10421

1 reference

2 August 2017

1 reference